Back

CHA2DS2-VASc below 3 predicts low one-year ischemic stroke risk in postoperative atrial fibrillation after CABG

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cardiovascular Surgery ePosters Coronary Arteries ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Amar Taha

Sahlgrenska University Hospital, Gothenburg (Sweden)

23 More presentations in this session

Presentation thumbnail
Prognosis of mitral valve regurgitation and left ventricular function in dual coronary repair for anomalous origin of left coronary artery from pulmonary artery (ALCAPA)
Doctor S. Kotit (Aswan, EG)
Abstract Slides
Presentation thumbnail
Right ventricular diastolic dysfunction and postoperative cardiac complications in patients undergoing coronary artery bypass grafting
Professor A. Sumin (Kemerovo, RU)
Abstract Slides
Presentation thumbnail
Early results of multiple coronary artery bypass grafting on arteries less than 1.5 mm in diameter
Mr V. Zaikovskii (Moscow, RU)
Abstract Slides
Presentation thumbnail
Percutaneous access versus surgical cutdown in TAVI: vascular and bleeding complications.
Doctor K. Stathogiannis (Stanford, US)
Abstract Slides
Presentation thumbnail
Preoperative anaemia is an independent predictor of 30-day mortality post-CABG and improves de predictive accuracy of EuroScore II
Doctor A. Rosler (Porto Alegre, BR)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular Surgery ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Anomalous left main coronary artery arising from the right coronary sinus presenting with ST elevation and non ST elevation myocardial infarction
thumbnail
Congress Presentation
Surgical correction of anomalous origin of the coronary artery: a scoping review on clinical outcomes, techniques, and knowledge gaps
thumbnail
Webinar
Chronic coronary syndrome post-myocardial infarction: disease progression and comorbidities

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources